drugset / Trial / NCT01504724

Effect of the Adjunctive IVB Before PRP

NCT01504724

Phase 4 Completed 30 enrolled Kyungpook National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to investigate the effect of adjunctive intravitreal bevacizumab (IVB) before panretinal photocoagulation (PRP) compared with only PRP on central macular thickness and retinal nerve fiber layer thickness in patients with severe diabetic retinopathy without macular edema.

Timeline

Start
2011-08
Primary completion
2012-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 1.25 mg Intravitreal

Indications